TW360646B - C2 taxane derivatives and pharmaceutical compositions containing them - Google Patents

C2 taxane derivatives and pharmaceutical compositions containing them

Info

Publication number
TW360646B
TW360646B TW083103421A TW83103421A TW360646B TW 360646 B TW360646 B TW 360646B TW 083103421 A TW083103421 A TW 083103421A TW 83103421 A TW83103421 A TW 83103421A TW 360646 B TW360646 B TW 360646B
Authority
TW
Taiwan
Prior art keywords
hydroxy
hydrogen
alkyl
phenyl
oxo
Prior art date
Application number
TW083103421A
Other languages
English (en)
Inventor
Robert A Holton
Chunlin Tao
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/010,798 external-priority patent/US5399726A/en
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of TW360646B publication Critical patent/TW360646B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW083103421A 1993-01-29 1994-04-18 C2 taxane derivatives and pharmaceutical compositions containing them TW360646B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/010,798 US5399726A (en) 1993-01-29 1993-01-29 Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
US3485293A 1993-03-22 1993-03-22
US9471593A 1993-07-20 1993-07-20

Publications (1)

Publication Number Publication Date
TW360646B true TW360646B (en) 1999-06-11

Family

ID=27359309

Family Applications (2)

Application Number Title Priority Date Filing Date
TW083103421A TW360646B (en) 1993-01-29 1994-04-18 C2 taxane derivatives and pharmaceutical compositions containing them
TW083104292A TW402598B (en) 1993-01-29 1994-05-12 C10 taxane derivatives and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW083104292A TW402598B (en) 1993-01-29 1994-05-12 C10 taxane derivatives and pharmaceutical compositions containing them

Country Status (13)

Country Link
EP (2) EP0681573B1 (zh)
JP (2) JP3452928B2 (zh)
CN (1) CN1125061C (zh)
AT (2) ATE220064T1 (zh)
AU (2) AU685778B2 (zh)
CA (2) CA2155013C (zh)
DE (2) DE69430902T2 (zh)
DK (1) DK0681573T3 (zh)
ES (1) ES2176237T3 (zh)
IL (1) IL108444A0 (zh)
PT (1) PT681573E (zh)
TW (2) TW360646B (zh)
WO (2) WO1994017052A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710287A (en) 1991-09-23 1998-01-20 Florida State University Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
IL108443A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C7 taxane derivatives and pharmaceutical compositions containing them
FR2702212B1 (fr) * 1993-03-02 1995-04-07 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5677470A (en) * 1994-06-28 1997-10-14 Tanabe Seiyaku Co., Ltd. Baccatin derivatives and processes for preparing the same
FR2723094A1 (fr) * 1994-07-26 1996-02-02 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
CA2162759A1 (en) * 1994-11-17 1996-05-18 Kenji Tsujihara Baccatin derivatives and processes for preparing the same
WO1998013359A1 (de) * 1996-09-24 1998-04-02 Marigen S.A. Ultramikroemulsionen aus spontan dispergierbaren konzentraten mit antitumoral und antiviral wirksamen estern von baccatin-iii-verbindungen
EP1067923A4 (en) * 1997-12-31 2002-11-13 Bristol Myers Squibb Co 2-AROYL-4-ACYL PACLITAXEL (TAXEL) ANALOGS
ITMI20021921A1 (it) * 2002-09-10 2004-03-11 Indena Spa Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali.
AU2005245396A1 (en) * 2004-05-14 2005-12-01 Immunogen, Inc. A facile method for synthesizing baccatin III compounds
US20130090484A1 (en) * 2011-10-11 2013-04-11 Scinopharm Taiwan Ltd. Process for making an intermediate of cabazitaxel
CN104250235B (zh) * 2014-09-24 2016-10-05 江苏红豆杉药业有限公司 一种紫杉醇的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942184A (en) * 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol

Also Published As

Publication number Publication date
ES2176237T3 (es) 2002-12-01
AU6132794A (en) 1994-08-15
JPH10502327A (ja) 1998-03-03
WO1994017052A1 (en) 1994-08-04
DE69430661T2 (de) 2002-10-24
DE69430902T2 (de) 2002-10-24
EP0681573A1 (en) 1995-11-15
EP0681575B1 (en) 2002-05-22
DE69430661D1 (de) 2002-06-27
DE69430902D1 (de) 2002-08-08
ATE217870T1 (de) 2002-06-15
JP3452928B2 (ja) 2003-10-06
CN1125061C (zh) 2003-10-22
EP0681575A4 (zh) 1995-12-13
AU684268B2 (en) 1997-12-11
CA2155013C (en) 2006-04-11
EP0681573A4 (zh) 1995-12-06
CA2155014C (en) 2007-06-26
AU6234094A (en) 1994-08-15
EP0681575A1 (en) 1995-11-15
DK0681573T3 (da) 2002-10-28
TW402598B (en) 2000-08-21
CA2155013A1 (en) 1994-08-04
PT681573E (pt) 2002-11-29
EP0681573B1 (en) 2002-07-03
WO1994017051A1 (en) 1994-08-04
JPH08506326A (ja) 1996-07-09
JP3741715B2 (ja) 2006-02-01
CN1101346A (zh) 1995-04-12
IL108444A0 (en) 1994-04-12
ATE220064T1 (de) 2002-07-15
CA2155014A1 (en) 1994-08-04
AU685778B2 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
TW360646B (en) C2 taxane derivatives and pharmaceutical compositions containing them
NO942428L (no) Nye sulfonamidopyrimidiner
ES1017717Y (es) Protector de agujas hipodermicas auto-retractiles.
GB2270075B (en) Substituted 2-phenyl-3-methoxypropenoate fungicides
NO943002L (no) Fosfono-oksymetyletere av taxanderivater
ZA929642B (en) Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor compound.
BR9205818A (pt) Composições azeotrópicas de 1,1,2,2-tetrafluororetano e semelhantes.
MX9204405A (es) Pigmentos de oxido metalico que contienen carbon.
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
EP0621692A3 (en) Surge protection circuit.
AP9400663A0 (en) Novel compounds.
UA29435C2 (uk) Похідні 3бета-алкенілпенаму та їх фармацевтично прийнятні солі
NO960632L (no) Nye bis-naftalimider for behandling av kreft
WO2000032577A3 (en) Substituted benzo[de]isoquinoline-1,3-diones
FR2684240B1 (fr) Transistor mos a zener de protection integree.
ATE205084T1 (de) 2,4-diaryl-1,3-dithiolane als platelet activating faktor rezeptorblocker und 5-lipoxygenasehemmer
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
ATE218858T1 (de) C9 taxanderivate und diese enthaltende pharmazeutische zusammensetzungen
EP0657443A4 (en) OPTICALLY ACTIVE CARBOXAMIDE DERIVATIVES.
IL106432A (en) Antimicrobial compositions containing 2-(2-bromo- 2-nitroethenyl) furan and methods for inhibiting the growth of microbes utilizing the same
DE59105006D1 (de) Carboxylgruppenhaltige Cyclohexanderivate.
GB0011927D0 (en) New use of citreamicins
TW374764B (en) Antitumor and antileukaemic compounds, their preparation and pharmaceutical composition containing them
MX9306822A (es) Derivados de oxa- y tiadiazol.
EP0618964A4 (en) Novel tissue plasminogen activator variants.

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees